Digilab BioVisioN receives ISO 9001:2000 Certificate
The successful ISO audit is an important milestone for the company in enabling its strategy of globally marketing both services and products based on Digilab's Peptidomics®-Technologies Platform for bioactive peptide and peptide biomarker discovery, validation, and development.
Dr. Wolfram Rodatz, Chief Executive Officer of Digilab BioVisioN, commented: "Digilab BioVisioN passed the ISO 9001 audit without any conditions for improvements or enhancements noted. This is an important recognition of the high quality control mechanisms implemented as an integral part of our operations since the company was founded in 1997. Our understanding of advanced Proteomics and Peptidomics® has allowed Digilab to expand its offering of services and products for our customers requiring peptide extraction and discovery from virtually all sample types."
Topics
Organizations
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.